SCHEMBL3446452

SCHEMBL3446452

CC(C)n1nnc2c(Nc3ccccc3)nc(NC3CCCCC3N)nc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 12/20 0.56
CLK2 P49760 12/20 0.56
CLK4 Q9HAZ1 11/20 0.56
CDK1 P06493 9/20 0.56
CCNB1 P14635 4/20 0.56
CDK4 P11802 2/20 0.56
CCND3 P30281 2/20 0.56
CLK3 P49761 1/20 0.51
CCNA2 P20248 3/20 0.50
CCNE1 P24864 3/20 0.50
CDK2 P24941 3/20 0.50
NPC1 O15118 1/20 0.50
CCNT1 O60563 1/20 0.50
EGFR P00533 1/20 0.50
PRKCA P17252 1/20 0.50
EIF2AK2 P19525 1/20 0.50
CCND1 P24385 1/20 0.50
MTOR P42345 1/20 0.50
CDK7 P50613 1/20 0.50
CDK9 P50750 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3445439 0.90 CLK1 (0.57) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3444790 0.90 CDK1 (0.51) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3445138 0.89 CLK1 (0.73) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3445723 0.87 CDK1 (0.53) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3445292 0.86 CDK2 (0.65) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3444351 0.85 CLK1 (0.72) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3445861 0.85 CLK1 (0.55) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3446354 0.85 CLK1 (0.55) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3445154 0.84 CDK1 (0.58) CLK1CLK2CLK4CDK1CCNB1
SCHEMBL3446815 0.84 CDK2 (0.61) CDK1CCNA2CCNE1CDK2PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816350-B2 Substituted [1,2,3] triazolo[4,5-D]pyrimidines as cdk inhibitors INSTITUTE OF EXPERIMENTAL BOTANY ASCR (CZ) 2010-10-19 US claimed